Improvement after a supplement is not the same as a comparative result
Start with the comparison. A before-and-after change alone cannot isolate the contribution of an ingredient.
Omega-3
Selected research topic
Cardiovascular events
Some measured outcomes improved in human comparison studies. Read these findings with their populations and conditions.
Some findings concern patients or people with a deficiency.
- Publications for this topic
- 2
- Human comparison publications
- 1
- Publications needing review
- 1
Findings in the studies
Major adverse cardiovascular events
- A better result than the comparison group was reported.
What the comparison group used was not confirmed.
Patient group · Separable contributionMeasurement and study conditions
- Study type
- Other evidence
- Study population
- Human participants · Patient group
- Ingredients tested
- Separable contribution
- How results were compared
- Results were compared between groups.
- Measurement time
- Not confirmed.
Representative outcome and study details
Human studies reported between-group improvement in Major adverse cardiovascular events.
Human studies · Includes patient groups · between-group comparison
1 publications linked to this result
- Route, form, dose, or population details are incomplete, so the findings cannot be confirmed as directly comparable.
Data coverage and detailed study classifications
Paper counts are separated by research topic below. One paper may contribute to multiple findings.
Analysis status: Public-ready
Ingredient analysis date:
How the grade was determined: C
The 50.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The C tier remains conservative because of the evidence centers on contextual or measured outcomes rather than general-use effects, limited repetition across independent human clinical studies.
The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.
Papers linked to this ingredient overall: 115
Papers linked to this topic 2 · distinct papers 2 · papers with a confirmed human comparison 1 · papers needing additional review 1
A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.
- Major adverse cardiovascular events: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
What the research found
Major adverse cardiovascular events
The study reported improvement in this measurement.
Other evidence · Separable contribution · Patient group
Between-group comparison
Analysis coverage and paper counts
1 paper · 1 measured outcome
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
Unspecified measured outcome
The study needs further checking before its result can be interpreted.
Controlled study in people · Ingredient combination · Patient group
Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.
The comparison could not be confirmed.
Analysis coverage and paper counts
1 paper · 1 measured outcome
1 papers held from direction counts
Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.
How to read research findings
How should I read research findings?
Research guidesNo clear difference and an uninterpretable result are different
A reported null comparison contains a result. An abstract without an interpretable comparison leaves a question unresolved.
Paper counts and study counts are different
Count original research separately from research that reanalyzes it. Publication volume is neither replication nor a quality rating.
Side effects and combination findings
Findings from this ingredient alone are shown separately from those involving another supplement or medication.
No combination cautions are available to show in the current data. This does not guarantee safety.
Review 2 combination findings and 0 findings that outperformed an ingredient alone.
Reported improvements with combinations
Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.
Combinations with reported improvement
The combination showed improvement, but each ingredient's contribution is unclear.
비타민 DCombined vitamin D and omega-3 fatty acids showed a 31% reduction in autoimmune disease incidence compared to placebo, suggesting a potential additive effect.
알파리포산The combination of omega-3 fatty acids and alpha-lipoic acid showed significant benefits in slowing cognitive and functional decline compared to placebo or omega-3 alone.